AI Insight
Researchers from Flinders University and international collaborators conducted a scoping review analyzing 2,441 records to examine patient perspectives on generative AI in cancer care. They found only 32 studies that investigated how cancer patients, survivors, and caregivers feel about the use of generative AI in their treatment and care. The research reveals a significant gap in patient engagement and input regarding AI implementation in oncology.
Why it matters
This finding highlights the need to include cancer patients and their caregivers in discussions about how AI technologies are developed and deployed in cancer treatment. Ensuring patient voices shape AI applications in oncology could lead to more patient-centered care and better acceptance of these technologies in clinical settings.
Understand the Science
Flinders University researchers were part of an international team that conducted a scoping review that identified 2,441 records and found that just 32 studies examined how cancer patients, survivors and caregivers feel about generative AI being used in their care. The study is published in the European Journal of Cancer.
Source: People affected by cancer need a stronger voice in shaping generative AI for oncology, review finds